Terms: = Ovarian cancer AND TNFRSF14, Q92956, 8764, ENSG00000157873, TR2, ATAR, LIGHTR, HVEM, HVEA
9 results:
1. Immune checkpoints as potential theragnostic biomarkers for epithelial ovarian cancer.
Habel A; Weili X; Hadj Ahmed M; Stayoussef M; Bouaziz H; Ayadi M; Mezlini A; Larbi A; Yaacoubi-Loueslati B
Int J Biol Markers; 2023 Dec; 38(3-4):203-213. PubMed ID: 37518940
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic relevance of HRDness gene expression signature in ovarian high-grade serous carcinoma; JGOG3025-tr2 study.
Takamatsu S; Yoshihara K; Baba T; Shimada M; Yoshida H; Kajiyama H; Oda K; Mandai M; Okamoto A; Enomoto T; Matsumura N
Br J Cancer; 2023 Apr; 128(6):1095-1104. PubMed ID: 36593360
[TBL] [Abstract] [Full Text] [Related]
3. Herpesvirus entry mediator regulates the transduction of Tregs via STAT5/Foxp3 signaling pathway in ovarian cancer cells.
Shan Y; Zhang B; Chen L; Zhang H; Jiang C; You Q; Li Y; Han H; Zhu J
Anticancer Drugs; 2023 Jan; 34(1):73-80. PubMed ID: 35946515
[TBL] [Abstract] [Full Text] [Related]
4. hvem/HIF-1α promoted proliferation and inhibited apoptosis of ovarian cancer cells under hypoxic microenvironment conditions.
Duan L; Tao J; Yang X; Ye L; Wu Y; He Q; Duan Y; Chen L; Zhu J
J Ovarian Res; 2020 Apr; 13(1):40. PubMed ID: 32312328
[TBL] [Abstract] [Full Text] [Related]
5. High expression of herpesvirus entry mediator (hvem) in ovarian serous adenocarcinoma tissue.
Fang Y; Ye L; Zhang T; He QZ; Zhu JL
J BUON; 2017; 22(1):80-86. PubMed ID: 28365939
[TBL] [Abstract] [Full Text] [Related]
6. Knockdown of hvem, a Lymphocyte Regulator Gene, in ovarian cancer Cells Increases Sensitivity to Activated T Cells.
Zhang T; Ye L; Han L; He Q; Zhu J
Oncol Res; 2016; 24(3):189-96. PubMed ID: 27458100
[TBL] [Abstract] [Full Text] [Related]
7. A role of BRCA1 and BRCA2 germline mutations in breast cancer susceptibility within Sardinian population.
Palomba G; Loi A; Uras A; Fancello P; Piras G; Gabbas A; Cossu A; Budroni M; Contu A; Tanda F; Farris A; Orrù S; Floris C; Pisano M; Lovicu M; Santona MC; Landriscina G; Crisponi L; Palmieri G; Monne M
BMC Cancer; 2009 Jul; 9():245. PubMed ID: 19619314
[TBL] [Abstract] [Full Text] [Related]
8. Construction of a fully retargeted herpes simplex virus 1 recombinant capable of entering cells solely via human epidermal growth factor receptor 2.
Menotti L; Cerretani A; Hengel H; Campadelli-Fiume G
J Virol; 2008 Oct; 82(20):10153-61. PubMed ID: 18684832
[TBL] [Abstract] [Full Text] [Related]
9. A herpes simplex virus recombinant that exhibits a single-chain antibody to HER2/neu enters cells through the mammary tumor receptor, independently of the gD receptors.
Menotti L; Cerretani A; Campadelli-Fiume G
J Virol; 2006 Jun; 80(11):5531-9. PubMed ID: 16699034
[TBL] [Abstract] [Full Text] [Related]
